期刊文献+

表浅膀胱癌灌注治疗副作用评估体系的探讨 被引量:4

下载PDF
导出
作者 任黎刚 邹强
出处 《临床泌尿外科杂志》 2004年第8期504-506,共3页 Journal of Clinical Urology
  • 相关文献

参考文献4

  • 1Lynch W J, Jenkins B J, Fowler C G, et al. The quality of life after radical radiotherapy for bladder cancer.Br J Urol, 1992, 70:519-521.
  • 2Lamm D L, Blumenstein B A, Crissman J D, Maintenance bacillus Calmette Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol, 2000, 163:1124-1129.
  • 3Van der Meijden A P, Brausi M, Zambon V, et al. Intravesical instillation of epirubicin, bacillus Calmette Guerin and bacillus Calmette Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder. a European Organization for Research and Treatment of Cancer genito urinary group randomized phase Ⅲ trial. J Urol, 2001, 166:476-481.
  • 4Welch G, Weinger K, Barry M J. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology,2002,59: 245- 250.

同被引文献23

  • 1姚剑.表阿霉素黏膜下浸润注射加单次灌注预防浅表性膀胱癌术后复发的研究[J].中华泌尿外科杂志,2004,25(10):679-681. 被引量:6
  • 2李传刚,刘用楫,范治璐,李荫田,张智勇,刘辉.榄香烯预防浅表性膀胱癌术后复发的临床观察[J].中华泌尿外科杂志,2005,26(4):237-239. 被引量:8
  • 3张志根,魏克湘,史时芳.经尿道电切术的内毒素血症[J].中华泌尿外科杂志,1995,16(5):282-285. 被引量:3
  • 4孙祥宙,戴宇平,丘少鹏,邓春华,郑克立.吡柔比星膀胱内灌注预防膀胱癌术后复发的临床研究[J].临床肿瘤学杂志,2005,10(2):157-158. 被引量:4
  • 5吴伟江,邹伟波,王行环,袁道彰,邹永锋.膀胱癌经尿道电切除术后吡柔比星膀胱灌注预防复发临床观察[J].临床泌尿外科杂志,2007,22(8):612-613. 被引量:19
  • 6Van-der-Meijden AP, Brausi M, Zambon V, et al. Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta,T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer genito-urinary group randomized phase Ⅲ trial [J]. J Urol, 2001,166(2):476-481.
  • 7Tsuji S, Matsumoto M, Takeuchi O, et al. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toil-like receptors [J]. Infect Immun, 2000, 68(12) :6883-6890.
  • 8Otto F, Schmid P, Macksen A, et al. Phase Ⅱ trial of intrvenous endotoxin in patients with colorectal and non-small cell lung cancer [J]. Eur J Cancer, 1996, 32A(10) :1712-1718.
  • 9Nagao S, Kawabata Y, Nishikawa T, et al. Endotoxin induces severe inflammatory reactions with necrosis at site primed with delayed-type hypersensitivity reactions in guinea pigs [J]. Microbiol Immunol, 1995, 39(12): 1011-1014.
  • 10Shahin 0,Thalmann GN,Rentsch C,et al. A retrospective analy-sis of 153 patients treated with or without intraavesical bacillusCalmette Guerin for primary stage 3 bladder cancer: recurrence,progression and survival. J Urol,2003,169:95-100.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部